In cases of gastric carcinomas, the immunohistochemical detection of CSNK2A1 expression has been found as a self-regulating prognostic factor associated with recurrence-free survival (RFS) and reduced overall survival in cancer patients [37]. This evidence concerns the gene CSNK2A1 and cancer.